Xiaoling Lin

177 papers receiving 2.4k citations

Peers

Xiaoling Lin
Comparison fields: 5 of 164
  • Molecular Medicine 115
  • Inorganic Chemistry 321
  • Cancer Research 264
  • Food Science 235
  • Molecular Biology 685
Replace Qingqing Xu with:
Qingqing Xu China
Shuang Zhang China
Caiyun Zhang China
Yaodong Zhang China
Ting Wang China
Jian Chen China
Yajuan Li China
Xinran Dong China
Zhaoxia Chen China
Nan Zhang China
Xiaoling Lin relative to Qingqing Xu China Qingqing Xu's profile →
Citations per field
00.5×2.6×
Qingqing Xu · 1×
Citations per year

Countries citing papers authored by Xiaoling Lin

Since Specialization
Citations

This map shows the geographic impact of Xiaoling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Lin more than expected).

Fields of papers citing papers by Xiaoling Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Lin. The network helps show where Xiaoling Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaoling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaoling Lin Line = papers co-authored together Xiaoling Lin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 198 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2014121
2 2021108
3 202193
4 201965
5 201353
6 202150
7 201547
8 201243
9 202143
10 202142
11 200741
12 202140
13 201440
14 202140
15 201837
16 201434
17 201632
18 201732
19 201332
20 202232

About Xiaoling Lin

Xiaoling Lin is a scholar working on Inorganic Chemistry, Molecular Medicine, Urology, Cancer Research and Psychiatry and Mental health, having authored 198 papers that have together received 2.5k indexed citations. Recurring topics across this work include Metal-Organic Frameworks: Synthesis and Applications (18 papers), Polyoxometalates: Synthesis and Applications (15 papers), Prostate Cancer Treatment and Research (10 papers), Genetic Associations and Epidemiology (9 papers), Bipolar Disorder and Treatment (9 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Viral Infections and Vectors (8 papers) and Integrated Circuits and Semiconductor Failure Analysis (8 papers). The work is most often cited by research in Molecular Medicine (115 citations), Inorganic Chemistry (321 citations), Cancer Research (264 citations), Food Science (235 citations) and Molecular Biology (685 citations). Xiaoling Lin has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Linjie Huang, Jun Ying, Xiuli Wang, Dali Lu, Shanping Jiang, Na Li, Yang Yang, Jianfeng Xu, Ai‐Xiang Tian and Zhiqiang Lv. Their work appears in journals such as The Prostate, Asian Journal of Andrology, Journal of Affective Disorders, Frontiers in Microbiology and BMC Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026